Jin Yang Pharmaceutical Co. Ltd (007370) — Capital Reinvestment Ratio
Latest as of March 2026:
0.04x
Jin Yang Pharmaceutical Co. Ltd (007370) has a Capital Reinvestment Ratio of 0.04x as of March 2026, meaning it reinvests 0% of its operating cash flow (₩4.53 Billion) in capital expenditures (₩197.80 Million). See 007370 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.04x
Capex / Operating Cash Flow
Operating Cash Flow
₩4.53 Billion
KRW
Capital Expenditures
₩197.80 Million
KRW
Data as of
Mar 2026
Most recent filing
Jin Yang Pharmaceutical Co. Ltd Capital Reinvestment Ratio (2018–2025)
This chart tracks Jin Yang Pharmaceutical Co. Ltd's Capital Reinvestment Ratio across 8 annual periods.
Annual Capital Reinvestment Ratio for Jin Yang Pharmaceutical Co. Ltd (2018–2025)
Year-by-year Capital Reinvestment Ratio for Jin Yang Pharmaceutical Co. Ltd from 2018 to 2025. For live market cap and broader valuation context, see market value of Jin Yang Pharmaceutical Co. Ltd.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 2.51x | ₩1.46 Billion | ₩3.67 Billion | ▲ +3285.2% |
| 2024 | 0.07x | ₩12.79 Billion | ₩947.22 Million | ▼ -58.8% |
| 2023 | 0.18x | ₩8.53 Billion | ₩1.53 Billion | ▼ -58.4% |
| 2022 | 0.43x | ₩7.45 Billion | ₩3.22 Billion | ▼ -66.2% |
| 2021 | 1.28x | ₩1.97 Billion | ₩2.52 Billion | ▲ +485.0% |
| 2020 | 0.22x | ₩6.24 Billion | ₩1.36 Billion | ▲ +113.6% |
| 2019 | 0.10x | ₩7.21 Billion | ₩736.71 Million | ▼ -67.0% |
| 2018 | 0.31x | ₩1.06 Billion | ₩327.39 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow